(Q44875555)
Statements
1 reference
Phase I and pharmacokinetic study of the ribonucleotide reductase inhibitor, 3-aminopyridine-2-carboxaldehyde thiosemicarbazone, administered by 96-hour intravenous continuous infusion (English)
1 reference
Mario Sznol
1 reference
Scott Wadler
1 reference
Della Makower
1 reference
Caroline Clairmont
1 reference
Paula Lambert
1 reference
Karen Fehn
1 reference
1 May 2004
1 reference
1 reference
22
1 reference
9
1 reference
1553-1563
1 reference
Identifiers
1 reference
1 reference